An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04946669 |
|
Recruitment Status :
Recruiting
First Posted : July 1, 2021
Last Update Posted : July 1, 2021
|
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Collaborator:
National Natural Science Foundation of China
Information provided by (Responsible Party):
Wenfeng Tan, The First Affiliated Hospital with Nanjing Medical University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 31, 2022 |
| Estimated Study Completion Date : | July 31, 2022 |